All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.

The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your GvHD Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
2019-12-16T10:59:46.000Z

How do you select the optimal donor for transplant?

Bookmark this article

The GvHD Hub are proud to present expert interviews directly from the 61st American Society of Hematology (ASH) meeting in Orlando, US. This interview with Arnon Nagler, Tel Aviv University, Tel Aviv, IL, was based on the question: How do you select the optimal donor for transplant?

Professor Nagler discusses the difficulties that can be faced in finding a matched donor, and notes that haploidentical transplant from a parent, sibling or child is more prominent but less successful. However, new technology, especially non-T-cell depleted transplant with GvHD prophylaxis now can yield good results with almost no difference observed between matched-unrelated and haploidentical donors.

Professor Nagler concludes that sibling donors are the optimal donor where possible, though if there is insufficient time to search for an unrelated donor, then non-T-cell depleted haploidentical transplant with post-transplant cyclophosphamide should be conducted.

How do you select the optimal donor for transplant?

Newsletter

Subscribe to get the best content related to GvHD delivered to your inbox